Meeting
2017 Gastrointestinal Cancers Symposium
The impact of the extent of gastric resection on advanced gastric cancer treated with systemic chemotherapy.
Authors
Yusuke Sasaki
Division of Medical Oncology, Hakodate Central General Hospital, Hokkaido, Japan
Yusuke Sasaki , Yutaka Watanabe , Ichiro Ohkita , Jojo Hirota , Jun Konno
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 194)
DOI
10.1200/JCO.2017.35.4_suppl.194
Abstract #
194
Poster Bd #
M20
Abstract Disclosures
Similar Posters
Poster
2015 Gastrointestinal Cancers Symposium
Long-term outcomes of preoperative chemotherapy with modified DCS therapy for highly advanced gastric cancer with distant metastasis.
First Author: Atsushi Matsuki
Poster
2014 Gastrointestinal Cancers Symposium
A multicenter, phase II study of trastuzumab plus capecitabine and oxaliplatin (XELOX) as first-line chemotherapy for HER2-positive advanced gastric cancer: Update results of efficacy and toxicity.
First Author: Jifang Gong
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Health-related quality of life (HRQOL) with pembrolizumab (pembro) plus trastuzumab (tras) and chemotherapy (chemo) in first-line HER2-positive (HER2+) advanced gastric cancer: KEYNOTE-811 trial results.
First Author: Yelena Y. Janjigian
First Author: Sylvie Lorenzen